Insight Online News
Thane, Jan 17 : SeQuent Scientific Limited (“SeQuent”) announced on Monday that its board of directors has appointed Rajaram Narayanan as managing director and chief executive officer (MD and CEO), effective from April 11, 2022.
Narayanan, who has served in senior leadership roles across the pharmaceutical, consumer goods and services industries, succeeds Manish Gupta who will be stepping down effective April 10, 2022 after serving as MD and CEO of SeQuent for the past eight years.
Gupta will continue to serve as a strategic advisor to the company until July 2022.
With over 25 years of experience, Narayanan will oversee the company’s next phase of growth and expansion.
Headquartered in Mumbai, SeQuent is India’s largest animal healthcare company and a top 20 animal health player globally. It is backed by global investment firm Carlyle.